Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus

Table 7 Logistic regression analysis of factors associated with metabolic-associated fatty liver disease (people living with human immunodeficiency virus and metabolic-associated fatty liver disease vs people living with human immunodeficiency virus and non-metabolic-associated fatty liver disease)

Factor	Exp(B)	95%CI	P value
AST	4.615	1.081-19.709	0.039a
Fasting Plasma glucose	21.5	5.327-86.767	< 0.001a
Triglyceride	6.747	1.747-26.047	0.006a
Total cholesterol	0.125	0.019-0.819	0.030a
LDL	12.97	1.983-84.827	0.007a
APOB rs10495712	4.195	1.304-18.532	0.019a
APOA5 rs662799	0.012	0.002-0.770	< 0.001a
LEP rs7799039	0.321	0.070-1.469	0.143a

^aP value < 0.2. AST: Aspartate aminotransaminase; LDL: Low-density lipoprotein.